TPMT and acute lymphoblastic leukemia: A recent study in ALL patients conducted by Stocco et al. [13] has shown that genetic variation in PACSIN2 also influences TPMT activity and is significantly associated with the incidence of 6-MP-related gastrointestinal toxicity [13].